Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 7:13 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.
View All Commentary (ONXX)
Recs
poling2482 (47.82) Submitted: 7/24/08 2:17 PM : Start Price: $38.39 ONXX Score: -2.07
A good buy at around $38. Great company with many new ideas will see a $50 price in near future.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK